Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an anticonvulsant presented as an oral formulation for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to control various seizure types.

- Partial seizures: decreases frequency of focal onset seizures and may reduce associated aura symptoms. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes and lowers the risk of injury during seizures. - Myoclonic seizures: reduces rapid muscle jerks and improves overall seizure control in patients with juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or lacking energy. - Headache: mild to moderate head pain. - Irritability: mood changes including increased agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: serious skin eruption requiring immediate medical attention. - Suicidal thoughts: emergence of depressive symptoms or urges to self‑harm.

When prescribing Levetiracetam, clinicians should consider several safety aspects to optimize therapy.

- Renal function: adjust dose in patients with impaired renal clearance. - Pregnancy: category B; use only when benefit outweighs potential risk. - Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. - Behavioral changes: observe for mood swings, aggression, or depression. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: enzyme induction may lower levetiracetam plasma concentrations. - Phenobarbital: strong enzyme inducer that can reduce therapeutic levels.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression may increase drowsiness. - Other antiepileptics: combined use may require dose adjustments. - Oral contraceptives: levetiracetam may decrease hormonal efficacy, necessitating alternative contraception.